Biome Technologies plc (LON:BIOM), a leading bioplastics and radio frequency technology business, announced that, following the exercise of options by a former employee, it has issued and allotted 18,733 ordinary shares of 5p each in the Company.
Application will be made to the London Stock Exchange for admission of 18,733 new Ordinary Shares to trading on AIM and dealings are expected to commence on 8 June 2021.
Following Admission, the total number of Ordinary Shares in issue will be 3,772,640 (including 16,710 Ordinary Shares held as treasury shares). Therefore, the total number of voting rights in the Company is 3,755,930 which may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules sourcebook.
Biome Technologies is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.
The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited.
